$27.51
+0 (+0%)
At Close: Jun 03, 2026
The Top Healthcare Stocks to Buy With $100
09:30am, Monday, 29'th May 2023
Pfizer is an old dog with big new tricks to come in the pharmaceutical sector. CVS has expanded beyond pharmacies to include health insurance and more.
Hims & Hers Stock: The Gift That Keeps On Giving
10:00am, Monday, 22'nd May 2023
Despite Hims & Hers delivering exceptional numbers on almost all KPI metrics, the stock has dipped by ~17.5% since the release of its Q1 report earlier this month. In this note, we will discuss Hims &
This Healthcare Innovator Is Up 235% in 12 Months: There's More Where That Came From
10:15am, Saturday, 13'th May 2023
Direct-to-consumer healthcare is proving lucrative. This company is growing subscribers by 87% year over year.
Is Hims & Hers Health (HIMS) Stock Outpacing Its Medical Peers This Year?
11:25am, Thursday, 11'th May 2023
Here is how Hims & Hers Health, Inc. (HIMS) and Apollo Medical Holdings, Inc. (AMEH) have performed compared to their sector so far this year.
Hims & Hers Health, Inc. (HIMS) Q1 2023 Earnings Call Transcript
08:49pm, Monday, 08'th May 2023
Hims & Hers Health, Inc. (NYSE:HIMS ) Q1 2023 Results Conference Call May 8, 2023 5:00 PM ET Company Participants Alice Lopatto - Vice President of Investor Relations Andrew Dudum - Chief Executive Of
Hims & Hers Health, Inc. (HIMS) Reports Q1 Loss, Tops Revenue Estimates
07:45pm, Monday, 08'th May 2023
Hims & Hers Health, Inc. (HIMS) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to loss of $0.08 per share a year ago.
Him & Hers raises full-year sales outlook, but stock falls
04:57pm, Monday, 08'th May 2023
Hims & Hers Health Inc. HIMS — the wellness company behind the online telehealth and prescription platforms Hims and Hers — on Monday reported a bigger per-share loss than expected for its first q
Could Hims & Hers Health Stock Help You Become a Millionaire?
07:50am, Saturday, 22'nd Apr 2023
Hims & Hers Health is putting up eye-popping growth. There's plenty of room for long-term expansion.
Hims & Hers Health, Inc. (HIMS) Surges 10.3%: Is This an Indication of Further Gains?
06:53am, Wednesday, 19'th Apr 2023
Hims & Hers Health, Inc. (HIMS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further stre
Hims & Hers to Announce First Quarter 2023 Financial Results on May 8, 2023
04:05pm, Monday, 17'th Apr 2023
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report first quarter 2023 financial res
Hims & Hers: I Might Buy The Rally
01:14pm, Wednesday, 12'th Apr 2023
Hims & Hers has maintained an extremely strong pace of revenue growth to reenergize previously flagging investor sentiment. Whilst its forward price-to-sales multiple has risen to eclipse most of its
5 Best and Worst Performing Mid-Cap Stocks in February 2023
10:58pm, Thursday, 09'th Mar 2023
Mid-cap stocks offer a balance between stability and growth prospects. On the one hand, they offer better growth prospects than large-cap stocks, and on the other, they carry lower risk and more stabi
Investors Cash In On 12 'Triple Play' Stocks That Do No Wrong
08:00am, Tuesday, 07'th Mar 2023
Investors are worried that S&P 500 stocks will let them down. So why not focus on the handful that are delivering perfection?
Hims & Hers Health: Proposed Telemedicine Regulation Could Materially Impact Sales
02:55am, Tuesday, 07'th Mar 2023
I previously rated HIMS as a buy and also mentioned the idiosyncratic regulatory risk the company is facing as a telemedicine operator. This has now come to fruition, with a new regulatory framework p
Not All Growth Stocks Are Dead With Austin Hankwitz (Cash Flow Freaks)
08:00pm, Wednesday, 01'st Mar 2023
We're joined by Austin Hankwitz from Cash Flow Freaks on Seeking Alpha. We dive into the Hims & Hers Health earnings report that was just announced.
Sign In
Buy HIMS